ePac Flexible Packaging Appoints Ryan Kiley to Drive ePacConnect

Innovative company invests to make Connected Packaging a reality for brands of all sizes

Austin, Texas USA, Nov. 30, 2020 (GLOBE NEWSWIRE) — ePac Flexible Packaging, the industry leader in digitally printed flexible packaging, has announced the appointment of Ryan Kiley to the position of Director, Market Development responsible for driving ePac’s connected packaging solution – ePacConnect on a global basis

In his most recent assignment, Mr. Kiley was with Ricoh North America for 13 years, and responsible for building the company’s production-class Software and Professional Service business unit. Previously, he spent 10 years with Rochester Software Associates as Director of Professional Services. Throughout Ryan’s career, he has successfully driven the development, sale, and services of digital print enabling software. 

According to Carl Joachim, ePac’s CMO: “To drive the market development of ePacConnect, we needed someone with a proven track record of success in software and professional services around production digital printing technologies. We’re excited to have Ryan on board to bring the capabilities of digitally produced connected packaging to our customers.”

ePacConnect leverages the power of digital printing to create serialized, trackable flexible packaging and new ways for brands to engage consumers, gain market insights and protect their brand. ePac will offer all its customers an entry-level no-cost solution, ideal for small and medium-sized brands, as well as a subscription fee-based solution for customers with broader requirements. By serializing each package it is automatically digitally enabled, given a unique digital identity, and can be “activated” at any time to give brands flexibility for how and when the codes are used. ePacConnect is currently being piloted in the United States and Europe with a full roll-out to all ePac locations planned in early 2021. 

About ePac Flexible Packaging

ePac’s founders began with a mission to provide locally-based consumer packaged goods companies the ability to compete with large brands with great packaging. ePac’s customers are predominantly local/regional small and medium-sized CPGs, many of whom are focused on creating natural and innovative products for consumers. Since opening its first manufacturing facility in 2016, ePac’s mission has been clear – to help small brands obtain big brand presence, give back to the communities it serves, and contribute to the creation of a more sustainable, circular economy. 

Attachments



Carl Joachim
ePac Flexible Packaging
+1 561-573-7992
[email protected]

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of bluebird bio, Inc. – BLUE

NEW YORK, Nov. 30, 2020 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of bluebird bio, Inc. (“bluebird” or the “Company”) (NASDAQ: BLUE). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.

The investigation concerns whether bluebird and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.



[Click here for information about joining the class action]

On November 4, 2020, bluebird disclosed that the Company will no longer be applying for U.S. Food and Drug Administration (“FDA”) approval of its bb1111 product as a treatment for sickle cell disease in the second half of 2021 as expected. Instead, citing “feedback” from the FDA, “alongside COVID-19 related shifts and contract manufacturing organization COVID-19 impacts, bluebird is adjusting its submission timing to late 2022.”

On this news, bluebird’s stock price fell $12.66 per share, or 21.62%, over the following two trading sessions, to close at $45.89 per share on November 6, 2020.

The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.

CONTACT:
Robert S. Willoughby
Pomerantz LLP
[email protected]
888-476-6529 ext. 7980



SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Molecular Templates, Inc. – MTEM

NEW YORK, Nov. 30, 2020 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Molecular Templates, Inc. (“Molecular” or the “Company”) (NASDAQ: MTEM).   Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. 

The investigation concerns whether Molecular and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 



[Click here for information about joining the class action]

On November 6, 2020, Molecular Templates disclosed that the U.S. Food and Drug Administration (“FDA”) had placed the Company’s “MT-3724 clinical studies on partial clinical hold following a treatment-related fatality in one subject who experienced Grade 5 capillary leak syndrome in the Phase 2 MT-3724 monotherapy study in in relapsed/refractory diffuse large B-cell lymphoma patients.”  Molecular Templates advised investors that the Company “is working to address the clinical and MT-3724 product lot information requests from the FDA and will then seek agreement from FDA to remove the partial clinical hold.” 

On this news, Molecular Templates’ stock price fell $2.30 per share, or 21.18%, to close at $8.56 per share on November 6, 2020.

The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.

CONTACT:
Robert S. Willoughby
Pomerantz LLP
[email protected]
888-476-6529 ext. 7980



SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Raytheon Technologies Corporation – RTX

NEW YORK, Nov. 30, 2020 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Raytheon Technologies Corporation (“Raytheon” or the “Company”) (NYSE: RTX). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.

The investigation concerns whether Raytheon and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 



[Click here for information about joining the class action]

On October 27, 2020, Raytheon filed its quarterly report for the third fiscal quarter with the U.S. Securities and Exchange Commission, in which the Company disclosed receipt of a criminal subpoena from the U.S. Department of Justice seeking information and documents in connection with an investigation relating to financial accounting, internal controls over financial reporting, and cost reporting regarding Raytheon’s Missiles & Defense business since 2009. 

On this news, Raytheon’s stock price fell $4.19 per share, or 7.4%, to close at $52.34 per share on October 28, 2020.

The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.

CONTACT:
Robert S. Willoughby
Pomerantz LLP
[email protected]
888-476-6529 ext. 7980



Progenity Announces Proposed Convertible Senior Notes Offering

SAN DIEGO, Nov. 30, 2020 (GLOBE NEWSWIRE) — Progenity, Inc. (NASDAQ: PROG) today announced its intention to offer, subject to market and other conditions, $75 million aggregate principal amount of convertible senior notes due 2025 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). Progenity also expects to grant the initial purchaser of the notes an option to purchase, for settlement within a period of 13 days from, and including, the date notes are first issued, up to an additional $15 million principal amount of notes.

The notes will be senior, unsecured obligations of Progenity, will accrue interest payable semi-annually in arrears and will mature on December 1, 2025, unless earlier repurchased, redeemed or converted. At any time from and including the date that is 30 calendar days after the initial closing date of the offering and before the close of business on the second scheduled trading day immediately before the maturity date, noteholders may convert their notes at their option into shares of Progenity’s common stock, together, if applicable, with cash in lieu of any fractional share, at the then-applicable conversion rate. In addition, noteholders that convert their notes before December 1, 2022 will, in certain circumstances, be entitled to an additional cash payment upon conversion. The notes will be redeemable, in whole and not in part, for cash at Progenity’s option at any time on or after December 1, 2023, but only if the last reported sale price per share of Progenity’s common stock exceeds 130% of the conversion price for a specified period of time. The redemption price will be equal to the principal amount of the notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date. The interest rate, initial conversion rate and other terms of the notes will be determined at the pricing of the offering.

Progenity intends to use the net proceeds from the offering, together with the net proceeds from the underwritten public offering of common stock referred to below, to support its operations, to invest in its molecular testing research and development program, to invest in research and development with respect to its precision medicine platform, and for working capital and general corporate purposes.

Certain entities affiliated with Athyrium Capital Management, LP (“Athyrium”), one of Progenity’s affiliates, have indicated their intent to acquire up to $103.5 million in aggregate principal amount of notes, consisting of up to $25 million principal amount of affiliate notes to be purchased for cash in the offering and, pursuant to a separate exchange agreement, up to an additional $78.5 million principal amount of affiliate notes to be issued in exchange for the discharge of amounts outstanding under Progenity’s credit and security agreement with a fund managed by Athyrium.

In a separate press release, Progenity also announced today its intention to offer, in a separate, underwritten public offering, subject to market and other conditions, $25 million of shares of its common stock, plus up to an additional $3.75 million of shares of its common stock that the underwriters of the common stock offering have the option to purchase from Progenity. The completion of the offering of the notes is not contingent on the completion of the offering of common stock, and the completion of the offering of common stock is not contingent on the completion of offering of the notes. This press release does not constitute an offer to sell, or the solicitation of an offer to buy, any common stock in the public offering.

The offer and sale of the notes and the shares of common stock issuable upon conversion of the notes have not been, and will not be, registered under the Securities Act or any other securities laws, and the notes and such shares cannot be offered or sold except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and any other applicable securities laws. This press release does not constitute an offer to sell, or the solicitation of an offer to buy, the notes or the shares of common stock issuable upon conversion of the notes, nor will there be any sale of the notes or such shares, in any state or other jurisdiction in which such offer, sale or solicitation would be unlawful.

About Progenity

Progenity, Inc. is a biotechnology company with an established track record of success in developing and commercializing molecular testing products, as well as innovating in the field of precision medicine. Progenity provides in vitro molecular tests designed to improve lives by providing actionable information that helps guide patients and physicians in making medical decisions during key life stages. The company applies a multi-omics approach, combining genomics, epigenomics, proteomics, and metabolomics to its molecular testing products and to the development of a suite of investigational ingestible devices designed to provide precise diagnostic sampling and drug delivery solutions. Progenity’s vision is to transform healthcare to become more precise and personal by improving diagnoses of disease and improving patient outcomes through localized treatment with targeted therapies.

Forward-Looking Statements

This press release includes forward-looking statements, including statements regarding the anticipated terms of the notes being offered, the completion, timing and size of the proposed offerings and the intended use of the proceeds. Forward-looking statements represent Progenity’s current expectations regarding future events and are subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those implied by the forward-looking statements. Among those risks and uncertainties are market conditions, including market interest rates, the trading price and volatility of Progenity’s common stock and risks relating to Progenity’s business, including those described in periodic reports that Progenity files from time to time with the SEC. Progenity may not consummate the proposed offerings described in this press release and, if the proposed offerings are consummated, cannot provide any assurances regarding the final terms of the offer or the notes or its ability to effectively apply the net proceeds as described above. The forward-looking statements included in this press release speak only as of the date of this press release, and Progenity does not undertake to update the statements included in this press release for subsequent developments, except as may be required by law.

Contact Information

Investor Contact:
Robert Uhl
Managing Director, Westwicke ICR
[email protected]
(619) 228-5886

Media Contact:
Kate Blom-Lowery
CG Life
[email protected] 
(858) 457-2436 



Progenity Announces Proposed Public Offering of Common Stock

SAN DIEGO, Nov. 30, 2020 (GLOBE NEWSWIRE) — Progenity, Inc. (“Progenity”) (NASDAQ: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products, today announced that it has commenced an underwritten public offering of $25 million of shares of its common stock. In addition, Progenity is expected to grant the underwriters of the offering an option for a period of 30 days to purchase up to an additional $3.75 million of shares of common stock at the public offering price, less the underwriting discounts and commissions. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed.

In a separate press release, Progenity also announced today its intention to offer, in a separate, private offering to qualified institutional buyers, subject to market and other conditions, $75 million aggregate principal amount of convertible senior notes due 2025 (the “notes”), plus up to an additional $15 million aggregate principal amount of notes that the initial purchaser of the notes has the option to purchase from Progenity. The completion of the offering of common stock is not contingent on the completion of the offering of the notes, and the completion of the offering of notes is not contingent on the completion of offering of common stock. This press release does not constitute an offer to sell, or the solicitation of an offer to buy, any notes or any shares of common stock issuable upon conversion of the notes.

Piper Sandler & Co. and Wells Fargo Securities, LLC are acting as joint book-running managers for the offering of common stock. BTIG, LLC is acting as the lead manager for the offering of common stock.

A registration statement relating to the offering of common stock has been filed with the Securities and Exchange Commission (“SEC”) but has not yet become effective. These securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective. This offering is being made only by means of a prospectus, copies of which may be obtained from Piper Sandler & Co., Attention: Prospectus Department, 800 Nicollet Mall, J12S03, Minneapolis, Minnesota 55402, or by telephone at (800) 747-3924, or by email at [email protected]; or Wells Fargo Securities, LLC, Attention: Equity Syndicate Department, 500 West 33rd Street, New York, New York, 10001, at (800) 326-5897 or email a request to [email protected].

This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Progenity

Progenity, Inc. is a biotechnology company with an established track record of success in developing and commercializing molecular testing products, as well as innovating in the field of precision medicine. Progenity provides in vitro molecular tests designed to improve lives by providing actionable information that helps guide patients and physicians in making medical decisions during key life stages. The company applies a multi-omics approach, combining genomics, epigenomics, proteomics, and metabolomics to its molecular testing products and to the development of a suite of investigational ingestible devices designed to provide precise diagnostic sampling and drug delivery solutions. Progenity’s vision is to transform healthcare to become more precise and personal by improving diagnoses of disease and improving patient outcomes through localized treatment with targeted therapies.

Forward Looking Statements

This press release contains “forward-looking statements,” which statements are subject to substantial risks and uncertainties and are based on estimates and assumptions. All statements, other than statements of historical facts included in this press release, including, but not limited to, Progenity’s expectations regarding the proposed offerings are forward-looking statements. In some cases, you can identify forward-looking statements by terms such as “may,” “might,” “will,” “objective,” “intend,” “should,” “could,” “can,” “would,” “expect,” “believe,” “design,” “estimate,” “predict,” “potential,” “develop,” “plan” or the negative of these terms, and similar expressions, or statements regarding intent, belief, or current expectations, are forward looking statements. These statements involve known and unknown risks, uncertainties and other factors that could cause Progenity’s actual results to differ materially from the forward-looking statements expressed or implied in this press release, the uncertainties related to market conditions and the completion of the offerings on the anticipated terms or at all, the uncertainties inherent in the clinical drug development process, such as the regulatory approval process, the timing of regulatory filings, and other matters, including the ongoing COVID-19 pandemic and associated shelter-in-place orders, that could affect sufficiency of existing cash, cash equivalents and short-term investments to fund operations and the availability or commercial potential of Progenity’s products, and those risks described in “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Progenity’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2020, filed with the SEC on November 11, 2020, and other subsequent documents filed with the SEC. Progenity claim the protection of the Safe Harbor contained in the Private Securities Litigation Reform Act of 1995 for forward-looking statements. Progenity expressly disclaims any obligation to update or alter any statements whether as a result of new information, future events or otherwise, except as required by law.

Investor Contact:
Robert Uhl
Managing Director, Westwicke ICR
[email protected]
(619) 228-5886

Media Contact:
Kate Blom-Lowery
CG Life
[email protected]
(619-743-6294)



SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Sio Gene Therapies, Inc. – AXGT

NEW YORK, Nov. 30, 2020 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Sio Gene Therapies, Inc. (“Sio” or the “Company”) (NASDAQ: AXGT). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.

The investigation concerns whether Sio and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.



[Click here for information about joining the class action]

On October 29, 2020, Sio disclosed that manufacturing delays would potentially postpone the start of enrollment in the Company’s planned randomized, sham-controlled trial of AXO-Lenti-PD gene therapy for Parkinson’s disease, and that the trial seemed unlikely to enroll patients by the end of the calendar year 2021.

On this news, Sio’s stock price fell $1.52 per share, or 41.64%, to close at $2.13 per share on October 30, 2020.

The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.

CONTACT:
Robert S. Willoughby
Pomerantz LLP
[email protected]
888-476-6529 ext. 7980



Magna Gold Corp. Announces Fiscal Year-End Change

PR Newswire

TORONTO, Nov. 30, 2020 /PRNewswire/ – Magna Gold Corp. (TSXV: MGR) (OTCQB: MGLQF) (“Magna” or the “Company“) is pleased to announce a fiscal year-end change from March 31 to December 31. This change will align the fiscal year-end of the Company with that of its subsidiaries, Molimentales del Noroeste, S.A. de C.V., LM Mining, S.A. de C.V. and Minera Magna, S.A. de C.V., which are required to have fiscal periods for Mexican tax purposes ending on December 31. With this change, the Corporation’s current fiscal year, which began on April 1, 2020, will end December 31, 2020. The notice of change of year-end required under National Instrument 51-102 – Continuous Disclosure Obligations will be filed under the Company’s profile at www.sedar.com.


About Magna Gold Corp.

Magna Gold Corp. is a Canadian gold company engaged in operations, development, exploration and acquisitions in Mexico. Its primary asset is the producing San Francisco gold mine in Sonora, Mexico and exploration stage projects include San Judas, La Pima and Mercedes.

The Company’s shares trade on the TSXV under the trading symbol “MGR” and OTCQB under the trading symbol “MGLQF”. Magna is well integrated into its nearby communities, employs local residents, and uses local services when possible.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cision View original content:http://www.prnewswire.com/news-releases/magna-gold-corp-announces-fiscal-year-end-change-301182058.html

SOURCE Magna Gold Corp.

SSR Mining Announces Positive Results of the Çöpler District Master Plan Studies

PR Newswire


The Master Plan Feasibility Level Study Reserve Case Produces an NPV 5% of $1.7 Billion


The Alternative PEA Case Including Ardich Resources Produces a Potential NPV 5% of $2.2 Billion

DENVER, Nov. 30, 2020 /PRNewswire/ – SSR Mining Inc. (NASDAQ: SSRM) (TSX: SSRM) (ASX: SSR) (“SSR Mining”) is pleased to announce the positive results of its independently prepared Master Plan study of the Çöpler District (“Çöpler District Master Plan 2020” or “CDMP20”) which will be set forth in an independent National Instrument 43-101 Technical Report on the Çöpler mine. Çöpler has been in continuous operations since 2010 and has cumulatively produced over 2 Moz of gold. The CDMP20 summarizes SSR Mining’s current development strategy for Çöpler and includes analysis for two production scenarios:

  1. Mineral Reserve case (the “Reserve Case”) incorporating a supplemental flotation circuit prepared to a Feasibility Study level; and
  2. An alternative Preliminary Economic Assessment case including the development of Ardich (the “PEA Case”). (1)


Highlights of the Çöpler District Master Plan 2020:


(All results on a 100% basis; currency in U.S. dollars)

  • Significant increase in Mineral Reserves and Mineral Resources: Updated figures and growth since December 31, 2019:
    • 4.0 Moz Mineral Reserves – increase of 22%;
    • 7.4 Moz Measured & Indicated Mineral Resources (2) – increase of 24%; and
    • 3.1 Moz Inferred Resources – increase of 58%.
  • Reserve Case outlines benefits of operational improvements and the addition of a supplemental flotation circuit:
    • NPV5% of $1.7 billion;
    • Life of mine production of 3.6 Moz of gold;
    • Average annual production of 266,000 ounces of gold over the first five years;
    • Average AISC of $865 per ounce (3) over the first five years;
    • Average annual free cash flow of $224 million(4) over the first five years;
    • Incorporation of supplemental flotation circuit: Increases sulfide plant throughput, lowers operating costs; and
    • 21-year asset life at higher processing rates: Mine life extension a result of lower processing costs, additional pit phases, additional tailings capacity, and an increased gold price.
  • PEA Case shows potentially robust economic results and increased production scale as a result of including development of the Ardich mineral resources:
    • NPV5% of $2.2 billion;
    • Life of mine production of 4.6 Moz of gold;
    • Average annual production of 306,000 ounces of gold over the first five years;
    • Average AISC of $886 per ounce (3) over the first five years;
    • Average annual free cash flow of $249 million(4) over the first five years;
    • 22-year asset life;
    • Ardich deposit incremental development capital of ~$50 million;
    • The Ardich deposit is a newly identified deposit that is separate to the other deposits on the property. Drilling is continuing at the Ardich deposit and it is expected that the drilling will further define the Mineral Resource; and
    • The PEA Case is preliminary in nature and includes an economic analysis that is based, in part, on Inferred Mineral Resources. Inferred Mineral Resources are considered too speculative geologically for the application of economic considerations that would allow them to be categorized as Mineral Reserves, and there is no certainty that the results will be realized. Mineral Resources that are not Mineral Reserves do not have demonstrated economic viability.
  • Approval for construction of the supplemental flotation circuit: SSR Mining’s Board of Directors has approved construction of the supplemental flotation circuit at a total cost of $18 million with commissioning expected in Q3 2021.

  • Permitting advancing: Permitting and Environmental Impact Assessment (“EIA”) updates for both Çöpler and Ardich are underway.

  • Tailings capacity constraint removed: A seventh lift of the tailings storage facility (“TSF”) along with improved settling, resulting from the flotation circuit removes the Mineral Reserve tailings capacity constraint on total tonnes processed. Engineering and permitting is proceeding on a second smaller tailings facility in anticipation of growth at Ardich and Çöpler.

  • Exploration continues at Ardich with positive drill results: Results from drilling completed since February 2020 provide encouragement for extension of the mineralized zones beyond the extents of the updated Mineral Resource. Drilling continues with three drills currently active.

Rod Antal, President and CEO stated, “We are pleased with the results of the updated Çöpler District Master Plan which demonstrates long-term value and the significant organic growth potential of this world-class operation. The CDMP20 clearly outlines a potential path to sustaining ~300,000 ounces of annual production from the district for at least 10 years, the extension of the overall mine life to 20+ years at increased processing rates, and the generation of robust free cash flows over the mine life.

In addition to numerous highly prospective targets identified within the district over the last several years, the subsequent Ardich drilling results, coupled with the C2 exploration results from last week, continue to indicate the significant upside we see at Çöpler for years to come. Ardich represents the most advanced project in the district with exploration, engineering, and permitting continuing to advance the project to potentially bring it into production by 2023.”


Çöpler District Master Plan 2020 Summary

The CDMP20 summarizes the current SSR Mining development strategy for Çöpler and includes analysis for two production scenarios:

  1. Reserve Case demonstrating the Mineral Reserves and incorporating a supplemental flotation circuit; and
  2. The alternative PEA Case outlining the development of Ardich.

A location plan showing the facility locations and the boundaries of the Reserve Case and the PEA Case is shown in Figure 1.

The CDMP20 scope included:

  • Updated Mineral Resource on the Çöpler, Çakmaktepe and Ardich deposits;
  • Updated Mineral Reserve on the Çöpler and Çakmaktepe deposits;
  • The incorporation of a supplemental flotation circuit in the existing sulfide plant; and
  • PEA which includes the preliminary development plan for the Ardich Mineral Resources.

Figure 1. CDMP20 Reserve Case and PEA Case Boundaries.

The Reserve Case is supported by feasibility study level work on the currently operated pits at the Çöpler and Çakmaktepe deposits, the heap leach facility, and the sulfide plant. The processing analysis in the Reserve Case includes incorporation of a flotation circuit into the existing sulfide plant to upgrade sulfide sulfur to fully utilize grinding and pressure oxidation (“POX”) autoclave capacity. The flotation circuit is in detailed design and preliminary construction works are underway pending final permitting which is expected in late 2020.

The PEA Case on an expanded Çöpler project includes the new predominantly oxide Ardich deposit for the enlarged project area, and that reflects the increased capital costs and infrastructure required. The PEA Case analyzes inclusion of production from Ardich in a whole of project analysis and represents a significant change from the Reserve Case economic results and production profile.

The key production and economic analysis from the CDMP20 are shown in Table 1.

Table 1. CDMP20 Results Summary.


Item


Unit


Reserve Case


PEA Case


Oxide Processed

Heap Leach Quantity

kt

7,668

25,008

Gold Feed Grade

g/t

1.22

1.69


Sulfide Processed

Quantity Milled

kt

51,084

54,073

Gold Feed Grade

g/t

2.24

2.33


Total Gold Produced

Oxide – Gold

koz

256

956

Sulfide – Gold

koz

3,334

3,691

Total – Gold

koz

3,591

4,646

Oxide – Gold Recovery

%

73

68

Sulfide – Gold Recovery

%

91

91


5-Year Annual Average

Average Gold Produced

koz

266

306

Free Cash Flow

$M

224

249

Production Costs (3)

$/oz Au

682

701

All–in Sustaining Costs (3)

$/oz Au

865

886


Key Financial Results

Production Costs (3)

$/oz Au

748

726

All–in Sustaining Costs (3)

$/oz Au

945

893

Site Operating Costs

$/t treated

47.09

42.87

After-Tax NPV (5%)

$M

1,733

2,164

Mine Life

years

21

22

Note: 5-Year annual average is for the period January 2021 to December 2025.


Sulfide Plant Flotation Circuit

A 50 to 150 tph flotation circuit will increase overall sulfide plant throughput, utilizing latent capacity in the sulfide plant, in particular the grinding and POX circuits. Total plant throughput will increase up to a maximum of 400 tph, depending on ore type and chemistry. Total plant and flotation circuit throughput will modulate to produce a concentrate that will maintain maximum autoclave sulfide sulfur throughput rates.

The flotation circuit is being installed between grinding and acidulation, as shown in Figure 2. A bleed / slip stream from the grinding thickener feed will go to flotation, gold bearing sulfide concentrate will return to the grinding thickener to be combined with POX feed. The carbonate rich flotation tailings go directly to leaching.

The projected benefits of the flotation circuit are:

  • A significant increase in overall plant throughput rate (1.9 to 2Mtpa design up to a max 3Mtpa);
  • Increased tailings settled density provides additional TSF capacity;
  • Reduced reagent usage (acid and lime); and
  • Making the sulfide plant less dependent on input ore chemical parameters (less process excursions & reduced mine costs).

Figure 2. Flotation circuit block flow diagram and graphics.

Figure 3. Flotation circuit graphics.

Figure 4. Flotation circuit graphics.


Ardich

The Ardich deposit is a newly discovered deposit that is separate to the other deposits on the property. Drilling is continuing at Ardich and is expected to further define and expand the Mineral Resource. The development of Ardich requires development of a new open pit that is 6 km from the current Çöpler pit and 1 km from the Çakmaktepe pit.

The PEA Case defines the first iteration of the potential development plan for Ardich. Permitting and planning for development is underway. The production profile of the PEA Case is outlined below in Figure 5.

Figure 5. PEA Case production profile.

Note: 2020E gold production of 330k ounces calculated based on year-to-date actual production of 244k ounces, plus 86k ounces of estimated gold production in Q4 2020.

Inferred Mineral Resources from Ardich are included in the PEA Case. The Ardich oxide Mineral Resources in the PEA Case for feed to the oxide heap leach represent a more than doubling of the production rate at an average grade that is 50% higher than the Çöpler oxide heap leach processing rate and average grade in the Reserve Case. The PEA Case includes assumptions for separate capital, infrastructure and permitting that will be required to develop the Ardich Mineral Resources. The Ardich Mineral Resource was not included in the previous Technical Report and so the PEA represents a significant change in information.

The PEA Case is preliminary in nature and includes an economic analysis that is based, in part, on Inferred Mineral Resources. Inferred Mineral Resources are considered too speculative geologically for the application of economic considerations that would allow them to be categorized as Mineral Reserves, and there is no certainty that the results will be realized. Mineral Resources that are not Mineral Reserves do not have demonstrated economic viability.


NPV Sensitivities

Figure 6. Reserve Case NPV Sensitivity.

Figure 7. PEA Case NPV Sensitivity.


Mineral Resources

Overall, there has been a 24% increase in Measured and Indicated contained gold and a 58% increase in Inferred contained gold. The new work has for the first time identified Measured Mineral Resources at Çöpler and Ardich.

The differences have been calculated between the CDMP20 Mineral Resources and the previous Mineral Resources reported as at December 31, 2019. The complete Mineral Resource is shown in Table 2 for each deposit, material type, and classification.

The differences are a function of the following changes:

  • Reduction in cut-off grades due to lower unit costs, higher throughputs in the sulfide plant, and increased gold price;
  • Larger conceptual pit shell selecting additional model cells above the cut-off;
  • Review of metallurgical recoveries;
  • Update to Çakmaktepe and Ardich resource models to incorporate recent drillhole data;
  • Review of Mineral Resource classification method; and
  • Depletion through mining since 31 December 2019.

Table 2. CDMP20 Mineral Resources Summary.


CDMP20 Mineral Resources Summary (as at the Effective Date)


Classification


Tonnage
(kt)


Grades


Contained Metal


Au (g/t)


Ag (g/t)


Cu (%)


Gold (koz)


Silver (koz)


Copper (klb)


Çöpler Mine Oxide Mineral Resource

Measured

287

1.29

7.75

0.09

12

72

540

Indicated

25,139

0.98

3.44

0.15

789

2,781

81,399

Measured + Indicated

25,427

0.98

3.49

0.15

801

2,853

81,939


Inferred


33,083


0.96


7.16


0.13


1,017


7,614


94,935


Çöpler Mine Sulfide Mineral Resource

Measured

2,454

2.22

7.21

175

569

Indicated

84,558

1.84

5.04

5,015

12,617

Measured + Indicated

87,012

1.86

4.71

5,190

13,186


Inferred


34,073


1.54


12.72




1,692


13,937




Çakmaktepe Oxide Mineral Resource

Measured

Indicated

3,626

1.53

8.50

179

993

Measured + Indicated

3,626

1.53

8.50

179

993


Inferred


1,205


0.85


4.04




33


157




Ardich Oxide Mineral Resource

Measured

4,707

1.63

246

Indicated

12,817

1.62

666

Measured + Indicated

17,524

1.62

912


Inferred


4,713


1.62






246






Ardich Sulfide Mineral Resource

Measured

695

2.56

57

Indicated

2,231

3.71

266

Measured + Indicated

2,926

3.43

323


Inferred


782


4.24






107






Bayramdere Oxide Mineral Resource

Measured

Indicated

145

2.34

20.82

11

97

Measured + Indicated

145

2.34

20.82

11

97


Inferred


8


2.17


19.95




1


5




CPMD20 Mineral Resources Total

Measured

8,143

1.87

2.45

0.00

490

641

540

Indicated

128,517

1.68

3.99

0.03

6,926

16,485

81,399

Measured + Indicated

136,660

1.69

3.90

0.03

7,416

17,126

81,939


Inferred


73,865


1.30


9.14


0.06


3,094


21,713


94,935

  • Mineral Resources have an effective date of November 27, 2020.
  • Mineral Resources are reported based on end of August 2020 topography surface.
  • Mineral Resources are reported inclusive of Mineral Reserves. Mineral Resources that are not Mineral Reserves do not have demonstrated economic viability.
  • Mineral Resources are shown on a 100% basis. Çöpler Mineral Resources are located on ground held 80% by SSR Mining, Çakmaktepe and Bayramdere Mineral Resources are located on ground held 50% by SSR Mining, and approximately 96% of Ardich Mineral Resources are located on ground held 80% by SSR Mining, with the remainder located on ground 50% held by SSR Mining.
  • Çöpler Sulfide Indicated total includes stockpiles: 6,674 kt @ 2.63 g/t Au (*).
  • Çakmaktepe Oxide Indicated total includes stockpiles: 11 kt @ 2.69 g/t Au (t).
  • At Çöpler: oxide is defined as material <2% total sulfur and sulfide material is ≥2% total sulfur.
  • At Ardich and Çakmaktepe, low-sulfur (LS) oxide is defined as material with <1% total sulfur, high-sulfur (HS) oxide is material with ≥1% and <2% total sulfur, and sulfide material is ≥2% total sulfur.
  • At Bayramdere: oxide is defined as material <2% total sulfur. There is no sulfide material at Bayramdere.
  • All Mineral Resources in the CDMP20 were assessed for reasonable prospects for eventual economic extraction by reporting only material that fell within conceptual pit shells based on metal prices of $1,750/oz for gold ($1,400/oz for gold and $19.00/oz for silver for Bayramdere). The following parameters were used:
    • Metallurgical recoveries in oxide: Çöpler 62.3%–78.4%, Çakmaktepe 38.0%–80.0%, Ardich 40.0%–73.0%, and Bayramdere 75.0%, and in sulfide: Çöpler 85.0%, and Ardich 82.9%;
    • Gold cut off grades in oxide: Çöpler 0.32–0.41 g/t Au, Çakmaktepe 0.36–0.76 g/t Au, Ardich 0.30–0.55 g/t Au, and Bayramdere 0.35–0.50 g/t Au, and in sulfide: Çöpler 0.73 g/t Au and Ardich 0.77 g/t Au, (there are no credits for Ag or Cu in the cut-off grade calculations); allowances have been made for royalty payable.
  • Reported Mineral Resources contain no allowances for unplanned dilution or mining recovery.
  • Totals may vary due to rounding.


Mineral Reserves

Overall, there has been a 39% increase in tonnage above the cut-off across both combined Mineral Reserve categories, with a corresponding 22% increase in contained gold. The major proportion of the increase is from larger pit design at Çöpler.

The differences have been calculated between the CDMP20 Mineral Reserves and the previous Mineral Reserves reported as at December 31, 2019. The complete Mineral Reserve is shown in Table 3 for each deposit, material type, and classification.

The differences are a function of the following changes:

  • New designs for two new phases beneath the Çöpler pit;
  • Reduction in cut-off grades from the increased throughput provided by the flotation circuit, reduced unit costs and increased gold price;
  • Review of metallurgical recoveries;
  • Review of Çakmaktepe North; and
  • Depletion through mining since December 31, 2019.

Table 3. CDMP20 Mineral Reserves Summary.


CDMP20 Mineral Reserves Summary (as at the Effective Date)


Classification


Tonnage
(kt)


Grades


Contained Metal


Au (g/t)


Ag (g/t)


Cu (%)


Gold (koz)


Silver (koz)


Copper (klb)


Çöpler Mine – Oxide

Proven Mineral Reserve

230

1.23

8.97

0.06

9

66

294

Probable Mineral Reserve

7,364

1.23

6.16

0.13

290

1,458

20,549

Probable – Stockpile

Total Mineral Reserve

7,595

1.23

6.24

0.12

299

1,525

20,843


Çöpler Mine – Sulfide

Proven Mineral Reserve

2,140

2.42

7.63

166

525

Probable Mineral Reserve

42,461

2.18

5.73

2,970

7,819

Probable – Stockpile

6,674

2.63

564

Total Mineral Reserve

51,274

2.24

5.06

3,700

8,344


Çakmaktepe Mine – Oxide

Proven Mineral Reserve

Probable Mineral Reserve

274

1.26

10.91

11

96

Probable – Stockpile

11

2.69

1

Total Mineral Reserve

285

1.32

10.49

12

96


CDMP20 – Oxide Reserve

Proven Mineral Reserve

230

1.23

8.97

0.06

9

66

294

Probable Mineral Reserve

7,638

1.23

6.33

0.13

301

1,554

20,549

Probable – Stockpile

11

2.69

1

Total Mineral Reserve

7,879

1.23

6.40

0.12

311

1,621

20,843


CDMP20 – Sulfide Reserve

Proven Mineral Reserve

2,140

2.42

7.63

166

525

Probable Mineral Reserve

42,461

2.18

5.73

2,970

7,819

Probable – Stockpile

6,674

2.63

564

Total Mineral Reserve

51,274

2.24

5.06

3,700

8,344


CDMP20 Mineral Reserves Total

Proven Mineral Reserve

2,370

2.30

7.76

0.01

175

591

294

Probable Mineral Reserve

50,099

2.03

5.82

0.02

3,272

9,373

20,549

Probable – Stockpile

6,685

2.63

564

Total Mineral Reserve

59,154

2.11

5.24

0.02

4,011

9,964

20,843

  • Effective date of the CDMP20 Mineral Reserve is November 27, 2020.
  • The Mineral Reserves were developed based on mine planning work completed in October 2020 and estimated based on End of August 2020 topography surface.
  • Mineral Reserve cut-offs are based on $1,350/oz Au gold price; average oxide recoveries are 73% and average sulfide recoveries are 91%.
  • Çöpler oxide cut-off grades 0.47–0.59 g/t Au, Çöpler sulfide cut-off grade 1.05 g/t Au, Çakmaktepe oxide cut off grades 0.52–0.71 g/t Au; all cut off grades include allowance for royalty payable. There are no credits for silver or copper in the cut-off grade calculations. There is no Çakmaktepe Sulfide Mineral Reserve.
  • Economic analysis has been carried out using a long-term gold price of $1,585/oz Au. The economic analysis has used a Q4’20 start date.
  • Mineral Reserves tabulated include 403 kt at 2.47 g/t Au from the mine plan scheduled for September 2020.
  • Totals may vary due to rounding.


Ownership

The Çöpler mine is owned and operated by Anagold Madencilik Sanayi ve Ticaret Anonim Şirketi (“Anagold”). SSR Mining controls 80% of the shares of Anagold, Lidya Madencilik Sanayi ve Ticaret A.Ş. (“Lidya”), controls 18.5%, and a bank wholly owned by Çalık Holdings A.Ş., holds the remaining 1.5%. Exploration tenures surrounding the project area and mining at Çakmaktepe are subject to joint venture agreements between SSR Mining and Lidya that have varying interest proportions. SSR Mining controls 50% of the shares of Kartaltepe Madencilik Sanayi ve Ticaret Anonim Şirketi and 50% of Tunçpinar Madencilik Sanayi ve Ticaret Anonim Şirketi. The other 50% is controlled by Lidya. Greater than 96% of the Mineral Resource is located on SSR Mining owned 80% ground, with the remainder of the mineralization within the 50/50% ownership boundary.


Qualified Persons

The following people served as the Qualified Persons (“QPs”) for the CDMP20 Technical Report as defined in National Instrument 43-101, Standards of Disclosure for Mineral Projects, and in compliance with Form 43-101F1:

  • Bernard Peters, BEng (Mining), FAusIMM (201743), employed by OreWin Pty Ltd as Technical Director – Mining, was responsible for the overall preparation of the CDMP20 and, the Mineral Reserve estimates; and
  • Sharron Sylvester, BSc (Geol), RPGeo AIG (10125), employed by OreWin Pty Ltd as Technical Director – Geology, was responsible for the preparation of the Mineral Resources.

Mr. Peters and Ms. Sylvester have each reviewed and approved the information in this news release relevant to the portion of the CDMP20 for which they are responsible.


Data Verification and QA/QC

Data verification procedures are well-established at the project. Routine ongoing checking of all data is undertaken prior to being uploaded to the database. This is followed by campaign-based independent data verification audits at milestone stages throughout data collection programs.

For drillhole data, verification includes the checking of DGPS collar coordinates relative to topographic surveys, checking of down-hole surveys relative to adjacent readings and planned dip and azimuth of the hole, checking logged data entries to ensure they are consistent with log key sheets, cross-checking a subset of assay data with the original laboratory reports, and submission of and review of QA/QC data.

The QA/QC program has historically consisted of a combination of QA/QC sample types that are designed to monitor different aspects of the sample preparation and assaying process: Blanks are routinely inserted in order to identify the presence of contamination through the sample preparation process; a variety of CRM standards are routinely inserted in order to monitor and measure the accuracy of the assay laboratory results over time; Field duplicates are routinely inserted as a means of monitoring and assessing sample homogeneity and inherent grade variability and to enable the determination of bias and precision between sample pairs; laboratory duplicates are inserted as a means of testing the precision of the laboratory measurements; and inter-laboratory pulp duplicates are submitted to alternative independent laboratory to assess for bias or drift. The rate of submission has been modified over time but is currently 3%–5% for blanks, CRMs, and duplicates, and 5%–10% for field duplicates.


Endnotes

  1. The PEA Case is preliminary in nature and includes an economic analysis that is based, in part, on Inferred Mineral Resources. Inferred Mineral Resources are considered too speculative geologically for the application of economic considerations that would allow them to be categorized as Mineral Reserves, and there is no certainty that the results will be realized. Mineral Resources that are not Mineral Reserves do not have demonstrated economic viability.
  2. Inclusive of Mineral Reserves.
  3. Production costs and AISC are determined on a per ounce gold produced basis and do not consider the application of inventory movements or deferred waste stripping. Production costs do not equate to cash costs prepared under SSR Mining non-GAAP measures. AISC do not equate to AISC prepared under SSR Mining non-GAAP measures.
  4. Free cash flow before interest and debt repayments.


About SSR Mining

SSR Mining Inc. is a leading, free cash flow focused intermediate gold company with four producing assets located in the USA, Turkey, Canada, and Argentina, combined with a global pipeline of high-quality development and exploration assets in the USA, Turkey, Mexico, Peru, and Canada. In 2019, the four operating assets produced over 720,000 ounces of gold and 7.7 million ounces of silver.

SSR Mining’s diversified asset portfolio is comprised of high margin, long-life assets along several of the world’s most prolific precious metal districts including the Çöpler mine along the Tethyan belt in Turkey; the Marigold mine along the Battle MountainEureka trend in Nevada, USA; the Seabee mine along the Trans-Hudson Corridor in Saskatchewan, Canada; and  the Puna mine along the Bolivian silver belt in Jujuy, Argentina. SSR Mining has an experienced leadership team with a proven track record of value creation. Across SSR Mining, the team has expertise in project construction, mining (open pit and underground), and processing (pressure oxidation, heap leach, and flotation), with a strong commitment to health, safety and environmental management.

SSR Mining intends to leverage its strong balance sheet and proven track record of free cash flow generation as foundations to organically fund growth across the portfolio and to facilitate superior returns to shareholders.

SSR Mining is listed under the ticker symbol SSRM on the NASDAQ and the TSX, and SSR on the ASX.


SSR Mining Contacts

F. Edward Farid, Executive Vice President, Chief Corporate Development Officer 

Michael McDonald, Director, Corporate Development & Investor Relations 

SSR Mining Inc. 
E-Mail: [email protected]
Phone: +1 (888) 338-0046 or +1 (604) 689-3846

To receive SSR Mining’s news releases by e-mail, please register using the SSR Mining website at

www.ssrmining.com

.


Cautionary Note Regarding Forward-Looking Statements

Except for statements of historical fact relating to us, certain statements contained in this news release constitute forward-looking information, future oriented financial information, or financial outlooks (collectively “forward-looking information”) within the meaning of Canadian securities laws. Forward-looking information may be contained in this document and our other public filings. Forward-looking information relates to statements concerning our outlook and anticipated events or results and in some cases, can be identified by terminology such as “may”, “will”, “could”, “should”, “expect”, “plan”, “anticipate”, “believe”, “intend”, “estimate”, “projects”, “predict”, “potential”, “continue” or other similar expressions concerning matters that are not historical facts.

Forward-looking statements in this news release are based on certain key expectations and assumptions made by us. Although we believe that the expectations and assumptions on which such forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because we can give no assurance that they will prove to be correct. Forward-looking statements are subject to various risks and uncertainties which could cause actual results and experience to differ materially from the anticipated results or expectations expressed in this news release. The key risks and uncertainties include, but are not limited to: local and global political and economic conditions; governmental and regulatory requirements and actions by governmental authorities, including changes in government policy, government ownership requirements, changes in environmental, tax and other laws or regulations and the interpretation thereof; developments with respect to the coronavirus disease 2019 (“COVID-19”) pandemic, including the duration, severity and scope of the pandemic and potential impacts on mining operations; risks associated with the merger transaction with Alacer Gold Corp.; and other risk factors detailed from time to time in our reports filed with the Canadian securities regulatory authorities.

Forward-looking statements in this news release include statements concerning, among other things: forecasts; outlook; timing of production; our intention to return excess attributable free cash flow to shareholders; future cash costs and AISC per payable ounce of gold, silver and other metals sold; the prices of gold, silver and other metals; our ability to discover new areas of mineralization, to add Mineral Reserves and to define additional Mineral Resources; the timing and extent of capital investment at our operations; the timing and extent of capitalized stripping at our operations; the timing of production and production levels; higher processed grades at Çöpler; free cash flow generation timing; the results of the 2020 Çöpler technical report, including the timing and preliminary capital estimate for the proposed flotation circuit, the impact of the proposed flotation circuit on total sulfide plant throughput and gold production and the results of production and exploration generally; the timing, focus and results of our exploration and development programs; Çöpler continuing to operate with limited impact from COVID-19, including exploration activities continuing as planned; current financial resources being sufficient to carry out plans, commitments and business requirements for the next twelve months; movements in commodity prices not impacting the value of any financial instruments; estimated production rates for gold, silver and other metals produced by us; the estimated cost of sustaining capital; ongoing or future development plans and capital replacement; estimates of expected or anticipated economic returns from our mining projects, including future sales of metals, concentrate or other products produced by us and the timing thereof; our plans and expectations for our properties and operations; and all other timing, exploration, development, operational, financial, budgetary, economic, legal, social, environmental, regulatory, and political matters that may influence or be influenced by future events or conditions.

Such forward-looking information and statements are based on a number of material factors and assumptions, including, but not limited in any manner to, those disclosed in any other of our filings, and include: the inherent speculative nature of exploration results; the ability to explore; communications with local stakeholders; maintaining community and governmental relations; status of negotiations of joint ventures; weather conditions at our operations; commodity prices; the ultimate determination of and realization of Mineral Reserves; existence or realization of Mineral Resources; the development approach; availability and receipt of required approvals, titles, licenses and permits; sufficient working capital to develop and operate the mines and implement development plans; access to adequate services and supplies; foreign currency exchange rates; interest rates; access to capital markets and associated cost of funds; availability of a qualified work force; ability to negotiate, finalize, and execute relevant agreements; lack of social opposition to our mines or facilities; lack of legal challenges with respect to our properties; the timing and amount of future production; the ability to meet production, cost, and capital expenditure targets; timing and ability to produce studies and analyses; capital and operating expenditures; economic conditions; availability of sufficient financing; the ultimate ability to mine, process, and sell mineral products on economically favorable terms; and any and all other timing, exploration, development, operational, financial, budgetary, economic, legal, social, geopolitical, regulatory and political factors that may influence future events or conditions. While we consider these factors and assumptions to be reasonable based on information currently available to us, they may prove to be incorrect.

You should not place undue reliance on forward-looking information and statements. Forward-looking information and statements are only predictions based on our current expectations and our projections about future events. Actual results may vary from such forward-looking information for a variety of reasons including, but not limited to, risks and uncertainties disclosed in our filings on our website at www.ssrmining.com, on SEDAR at www.sedar.com, on EDGAR at www.sec.gov and on the ASX at www.asx.com.au and other unforeseen events or circumstances. Other than as required by law, we do not intend, and undertake no obligation to update any forward-looking information to reflect, among other things, new information or future events.

Cautionary Note to U.S. Investors

This news release includes Mineral Reserves and Mineral Resources classification terms that comply with reporting standards in Canada and the Mineral Reserves and the Mineral Resources estimates are made in accordance with NI 43-101. NI 43-101 is a rule developed by the Canadian Securities Administrators that establishes standards for all public disclosure an issuer makes of scientific and technical information concerning mineral projects. These standards differ significantly from the requirements of the SEC set out in SEC Industry Guide 7. Consequently, Mineral Reserves and Mineral Resources information included in this news release is not comparable to similar information that would generally be disclosed by domestic U.S. reporting companies subject to the reporting and disclosure requirements of the SEC. Under SEC standards, mineralization may not be classified as a “reserve” unless the determination has been made that the mineralization could be economically produced or extracted at the time the reserve determination is made.

In addition, the SEC’s disclosure standards normally do not permit the inclusion of information concerning “Measured Mineral Resources,” “Indicated Mineral Resources” or “Inferred Mineral Resources” or other descriptions of the amount of mineralization in mineral deposits that do not constitute “reserves” by U.S. standards in documents filed with the SEC. U.S. investors should understand that “Inferred Mineral Resources” have a great amount of uncertainty as to their existence and great uncertainty as to their economic and legal feasibility. Moreover, the requirements of NI 43-101 for identification of “reserves” are also not the same as those of the SEC, and reserves reported by us in compliance with NI 43-101 may not qualify as “reserves” under SEC standards. Accordingly, information concerning mineral deposits set forth herein may not be comparable with information made public by companies that report in accordance with U.S. standards.

Cautionary Note Regarding Non-GAAP Measures

This news release includes certain terms or performance measures commonly used in the mining industry that are not defined under International Financial Reporting Standards (“IFRS”), including free cash flow, cash costs and AISC per payable ounce of gold and silver sold, and realized metal prices. Non-GAAP measures do not have any standardized meaning prescribed under IFRS and, therefore, they may not be comparable to similar measures employed by other companies. We believe that, in addition to conventional measures prepared in accordance with IFRS, certain investors use this information to evaluate our performance. The data presented is intended to provide additional information and should not be considered in isolation or as a substitute for measures of performance prepared in accordance with IFRS. Readers should refer to our management’s discussion and analysis, available under our corporate profile at www.sedar.com or on our website at www.ssrmining.com, under the heading “Non-GAAP Financial Measures” for a more detailed discussion of how we calculate such measures and a reconciliation of certain measures to GAAP terms.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/ssr-mining-announces-positive-results-of-the-copler-district-master-plan-studies-301182048.html

SOURCE SSR Mining Inc.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Vasta Platform Limited – VSTA

NEW YORK, Nov. 30, 2020 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Vasta Platform Limited (“Vasta” or the “Company”) (NASDAQ: VSTA). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.

The investigation concerns whether Vasta and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.



[Click here for information about joining the class action]

On or about July 31, 2020, Vasta conducted its initial public offering (“IPO”), selling approximately 18.6 million shares of stock priced at $19.00 a share, raising nearly $353 million in new capital. Then, on August 20, 2020, Vasta announced the Company’s financial results for the second quarter and the first half of 2020. Among other results, Vasta reported a second-quarter net loss of 54.9 million Reais and revenue of 120.23 million Reais, representing a revenue decline of 12.9% from the same period in the prior year.

On this news, Vasta’s stock price fell $1.63 per share, or 8.81%, to close at $16.88 per share on August 21, 2020.

The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.

CONTACT:
Robert S. Willoughby
Pomerantz LLP
[email protected]
888-476-6529 ext. 7980